BioSpace News Archive

Business

Melinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor Relations

DeFrancesco is a seasoned healthcare industry executive, with 18 years of experience in investor relations, finance and communications.

January 2, 2018
·
7 min read
GN Store Nord: Transactions in Relation to Share Buyback Program - Jan. 2 2018

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

January 2, 2018
·
2 min read
Business

A&E Medical Board Names Eric Sklar as President and Chief Executive Officer

A&E Medical announced that Eric Sklar has been named Chief Executive Officer, effective immediately.

January 2, 2018
·
2 min read
Genetown

Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Akebia Therapeutics today announced that the Company granted six newly-hired employees options to purchase an aggregate of 30,500 shares of Akebia’s common stock with a per share exercise price of $14.87, the closing price on the grant date.

January 2, 2018
·
1 min read
BioMidwest

WishBone Medical Releases Broken Screw Removal and K-Wire Systems

The Broken Screw Removal System is available in three different sizes: 2.7mm, 3.5mm and 4.5mm and is designed to remove broken, stripped and cold-welded screws.

January 2, 2018
·
1 min read
Drug Development

BeiGene Initiates Global Phase III Trial of Anti-PD-1 Antibody Tislelizumab in Patients With Hepatocellular Carcinoma

The Phase 3 trial is designed to compare the efficacy and safety of tislelizumab versus sorafenib as a potential first-line treatment in patients with unresectable HCC.

January 2, 2018
·
6 min read
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017

Here’s a table that provides the total number of shares and voting rights in Veloxis as of 31 December 2017.

January 2, 2018
·
1 min read
FDA

Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP

The Phendimetrazine Tartrate approval is from an Elite ANDA filed approximately six years ago.

January 2, 2018
·
3 min read
Policy

Kessler Topaz Represents Investors in $290M Total Settlement Recovery Reached with Valeant Pharmaceuticals and Bill Ackman’s Pershing Square Over Insider Trading Claims

In settling the claims, Valeant and Pershing Square agreed to jointly pay a total of $290M for all involved investors.

January 2, 2018
·
2 min read
LSKB Announces Official Nonproprietary Naming of Apatinib (YN968D1): RIVOCERANIB

LSKB announced that it has adopted the nonproprietary/generic name “rivoceranib” for its small molecule angiogenesis inhibitor commonly known as apatinib and YN968D1.

January 2, 2018
·
3 min read